Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation

Transplant Proc. 1993 Apr;25(2):1870-1.

Authors

D Lange¹, W O Bechstein, G Blumhardt, P Lemmens, N Schattenfroh, P Neuhaus

Affiliation

¹ Department of Surgery, Universitätsklinikum Rudolf-Virchow, Freie Universität Berlin, Germany.

PMID: 8470207

No abstract available

Publication types

Clinical Trial
Comparative Study
Multicenter Study

MeSH terms

Antilymphocyte Serum / therapeutic use
Azathioprine / therapeutic use
Biopsy
Cyclosporine / therapeutic use
Drug Resistance
Drug Therapy, Combination
Graft Rejection / immunology
Graft Rejection / pathology
Graft Rejection / therapy*
Humans
Immunosuppressive Agents / therapeutic use*
Liver Function Tests
Liver Transplantation / immunology*
Liver Transplantation / mortality
Liver Transplantation / pathology
Muromonab-CD3 / therapeutic use*
Prednisolone / therapeutic use*
Retrospective Studies
Survival Analysis
Treatment Outcome

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Muromonab-CD3
Cyclosporine
Prednisolone
Azathioprine